Chronic Hepatitis C Treatment with New Antiviral Agents
Journal Title: Mediterranean Journal of Infection, Microbes and Antimicrobials - Year 2018, Vol 7, Issue 1
Abstract
Recent advances in our knowledge of hepatitis C virus (HCV) molecular biology have enabled improvements in the efficacy and tolerability of HCV treatment, and in this regard many direct-acting antiviral (DAA) agents have been developed. These drugs target specific stages in the HCV life cycle. Phase 3 clinical trials have demonstrated treatment success rates of 90% with these drugs and their combinations, while real world data indicate a rate of 80-90%. In this review, the use of DAA drugs in the treatment of chronic HCV infection is reviewed in detail.
Authors and Affiliations
Özlem KANDEMİR
Keywords
Related Articles
- EP ID EP689309
- DOI 10.4274/mjima.2018.9
- Views 148
- Downloads 0
Cefoxitin: Interesting Perspectives on a Neglected Intravenous Beta-lactam
Cefoxitin is a beta-lactam antibiotic belonging to the cephamycins class, up to now only used in clinical practice for prophylaxis during surgery. Recently, its use has increased due to the spread of infections caused by...
Evaluation of Risk Factors Associated with HBsAg and Anti-HCV Seropositivity: Results of a Nationwide Population-based Epidemiological Survey Study in Turkey
Introduction: In this study, it was aimed to evaluate factors associated with hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (HCV) positivity through the “Raising Public Awareness and Determining Epidemio...
Hantavirus Infections in Light of Current Knowledge
Hantavirus is an enveloped virus with an RNA genome comprised of three negative-sense, single-stranded segments and belongs to the genus Hantavirus in family Bunyaviridae. Human infections are seen in two different clini...
Epidemiology of Multidrug-resistant Organisms in Africa
Multidrug-resistant organisms/bacteria (MDROs) have significant health implications that either have not been addressed or received only limited attention, especially in resource-constrained settings such as Africa, wher...
Current Diagnosis and Treatment Approach to Sepsis
Sepsis is a major healthcare problem worldwide. Its mortality and morbidity is still high. Early diagnosis of sepsis and appropriate management in the initial hours improve outcomes. The Surviving Sepsis Campaign publish...